Stereoselective Biotransformation of the Selective Serotonin Reuptake Inhibitor Citalopram and Its Demethylated Metabolites by Monoamine Oxidases in Human Liver
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
1951 • 319,299 citations
Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
1995 • 601 citations
The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer
1992 • 321 citations
Monoamine oxidase—I
1974 • 318 citations
A Double-Blind, Placebo-Controlled Study of Citalopram With and Without Lithium in the Treatment of Therapy-Resistant Depressive Patients
1996 • 168 citations
Use of in vitro human metabolism studies in drug development
1994 • 142 citations
Interactions of monoamine oxidase with substrates and inhibitors
1989 • 141 citations
Adrenaline and amine oxidase
1937 • 132 citations
Analysis of Enantiomers of Citalopram and Its Demethylated Metabolites in Plasma of Depressive Patients Using Chiral Reverse-Phase Liquid Chromatography
1995 • 126 citations
Neuroendocrine Effects of a 20-mg Citalopram Infusion in Healthy Males A Placebo-Controlled Evaluation of Citalopram as 5-HT Function Probe
1996 • 109 citations
Pharmacology and pharmacokinetics of citalopram and other SSRIs
1996 • 109 citations
Tyramine oxidase
1937 • 96 citations
Selective inhibitors of monoamine oxidase (MAO‐A and MAO‐B) as probes of its catalytic site and mechanism
1995 • 91 citations
Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver
1994 • 85 citations
Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases
1994 • 77 citations
Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC
1995 • 72 citations
High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients
1984 • 67 citations
Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation
1996 • 67 citations
Xen0biotic Oxidation Catalyzed by Aldehyde Dehydrogenases
1989 • 66 citations
Monoamine oxidases: old friends hold many surprises
1995 • 65 citations
Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation
1987 • 63 citations
Xenobiotic Metabolism in Brain
1995 • 55 citations
GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin
1988 • 44 citations
Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography—mass spectrometry
1993 • 40 citations
Inhibition by SKF-525A of the aldehyde oxidase-mediated metabolism of the experimental antitumour agent acridine carboxamide
1993 • 27 citations
Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine
1996 • 23 citations
Hepatic microsomal oxygenation of aldehydes to car☐ylic acids
1990 • 22 citations
Chronic administration of citalopram inhibited El mouse convulsions and decreased monoamine oxidase-A activity.
1994 • 16 citations
Metabolism of diltiazem. III. Oxidative deamination of diltiazem in rat liver microsomes.
1990 • 14 citations
Extrahepatic Microsomal Forms: Brain Cytochrome P450
1993 • 14 citations
On the stereospecificity of monoamine oxidase
1982 • 11 citations
Oxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.
1995 • 10 citations
Pharmacogenetic variability in brain and muscle.
1994 • 6 citations
Metabolic Formation of Dimethylamine and Methylamine from Basic Drugs Containing N-Methyl Group: A Newly Established Chromatographic Assay and Its Application to the Determination of Deaminase Activity.
1993 • 4 citations